Clinical TrialID 3725
Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
NCT03755778
RSV Infection
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3725
- Evidence Id
- 3725
- Core Evidence Id
- 3725
- Source Clinical Trial Id
- 3698
- Herb2 Clinical Trial Id
- HBCT003698
- Nct Id
- NCT03755778
- Title
- Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- RSV Infection
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
- Intervention
- DRUG: EDP-938|DRUG: EDP-938|DRUG: EDP-938|DRUG: Itraconazole|DRUG: Rifampin|DRUG: Quinidine
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Basic_Science
- Gender
- All
- Age
- Adult
- Enrollment
- 72
- Outcome Measure
- Cmax of EDP-938 with and without coadministration with itraconazole, Up to 19 days|AUC of EDP-938 with and without coadministration with itraconazole, Up to 19 days|Cmax of EDP-938 with and without coadministration with rifampin, Up to 17 days|AUC of EDP-938 with and without coadministration with rifampin, Up to 17 days|Cmax of EDP-938 with and without coadministration with quinidine, Up to 13 days|AUC of EDP-938 with and without coadministration with quinidine, Up to 13 days
- Sponsor Collaborator
- Enanta Pharmaceuticals, Inc|Pharmaceutical Research Associates
- Funded By
- INDUSTRY
- Location
- Pharmaceutical Research Associates, Inc.,, Lenexa, Kansas, 66219, United States
- Other Id
- EDP 938-003
- Start Date
- 2018-11-29
- Primary Completion Date
- 2019-01-21
- Completion Date
- 2019-01-27
- First Posted
- 2018-11-28
- Results First Posted
- Last Update Posted
- 2019-06-14
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03755778
- Title Cn
- Title En
- Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects
- Bilingual Status
- semi_complete